Cyclacel Pharmaceuticals to Release Second Quarter 2020 Financial Results

NEXT STORY
Worldwide Post-Pandemic Healthcare Market Study 2020 – COVID-19 Impact
PREV STORY
Affimed Announces Two New Appointments to Its Supervisory Board
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Everest Medicines Announces First Patient Dosed in Phase 3 Registration Asian Study of TrodelvyTM (sacituzumab govitecan) for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer

author_avatar
NASDAQ Market News

Genetron Health Reveals Two Cancer Research Study Results at the Association for Molecular Pathology 2021 Annual Meeting

author_avatar
NASDAQ Market News

Athenex Announces Participation in the 2020 RBC Capital Markets Global Healthcare Virtual Conference

author_avatar
NASDAQ Market News